Literature DB >> 16549608

Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach.

Andrew F Scarsbrook1, Rajesh V Thakker, John A H Wass, Fergus V Gleeson, Rachel R Phillips.   

Abstract

Multiple endocrine neoplasia (MEN) is characterized by the occurrence of two or more tumors that may be associated with hyperfunction and malignancy. MEN is caused by genetic defects, and two major types, MEN 1 and MEN 2, are recognized. Each type is characterized by the development of tumors within specific endocrine organs. A multidisciplinary approach involving cooperation between endocrinologists, surgeons, oncologists, and radiologists is pivotal for optimizing patient treatment. Imaging plays a vital role in the diagnosis and management of the disease. To contribute effectively, however, the radiologist must understand the range of anatomic and functional imaging modalities used in the assessment of endocrine disorders. In addition, knowledge of the optimal techniques for evaluating the pituitary, thyroid, parathyroid, pancreatic, adrenal, and foregut carcinoid tumors that occur in these MEN syndromes is essential. Finally, an understanding of the spectrum of disease and of the manifestations of each component is crucial for accurate detection, staging, and surveillance in this diverse patient group. (c) RSNA, 2006.

Entities:  

Mesh:

Year:  2006        PMID: 16549608     DOI: 10.1148/rg.262055073

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  8 in total

1.  Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Max B Albers; Damiano Librizzi; Caroline L Lopez; Jerena Manoharan; Jonas C Apitzsch; Emily P Slater; Carmen Bollmann; Peter H Kann; Detlef K Bartsch
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

2.  Clinics in diagnostic imaging (210). Primary hyperparathyroidism (PHPT) due to parathyroid adenoma.

Authors:  Michael John Clarke; Syed Zama Ali
Journal:  Singapore Med J       Date:  2021-06       Impact factor: 1.858

3.  Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.

Authors:  Clément Morgat; Fritz-Line Vélayoudom-Céphise; Paul Schwartz; Martine Guyot; Delphine Gaye; Delphine Vimont; Jürgen Schulz; Joachim Mazère; Marie-Laure Nunes; Denis Smith; Elif Hindié; Philippe Fernandez; Antoine Tabarin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-28       Impact factor: 9.236

4.  Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A.

Authors:  Kun-Long Tang; Yi Lin; Li-Ming Li
Journal:  World J Surg Oncol       Date:  2014-01-09       Impact factor: 2.754

5.  CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.

Authors:  Nassim Fard; Heinz-Peter Schlemmer; Friedhelm Raue; Björn Jobke
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

6.  Multimodality appearance of multiple endocrine neoplasia type 1: A case report.

Authors:  John Monge; Daniel Homuth; Loren Zuiderveld
Journal:  Radiol Case Rep       Date:  2019-01-23

7.  Coexistence of Renin-independent Aldosterone Secretion and Multiple Endocrine Neoplasia Type 1 Within a Family.

Authors:  Yoshinari Obata; Kana Takayama; Yumiko Maruo; Hiroki Yamaguchi; Kohei Fujii; Sonyun Hata; Yuri Togawa; Azusa Sanda; Motohiro Kosugi; Yoji Hazama; Tetsuyuki Yasuda
Journal:  J Endocr Soc       Date:  2022-01-29

Review 8.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.